CASI logo

CASI Pharmaceuticals (CASI) Shareholders Equity

CASI Annual Shareholders Equity

$24.16 M
-$20.41 M-45.79%

31 December 2023

CASI Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Quarterly Shareholders Equity

$13.85 M
+$4.83 M+53.50%

01 September 2024

CASI Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.8%-42.7%
3 y3 years-70.4%-42.7%
5 y5 years-77.9%-42.7%

CASI Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-71.4%at low-83.6%+53.5%
5 y5-year-71.4%at low-86.2%+53.5%
alltimeall time-77.9%+497.0%-87.8%+252.7%

CASI Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$13.85 M(+53.5%)
June 2024
-
$9.02 M(-41.7%)
Mar 2024
-
$15.47 M(-36.0%)
Dec 2023
$24.16 M(-45.8%)
$24.16 M(-16.1%)
Sept 2023
-
$28.79 M(-10.6%)
June 2023
-
$32.23 M(-18.6%)
Mar 2023
-
$39.58 M(-11.2%)
Dec 2022
$44.57 M(-47.3%)
$44.57 M(-27.8%)
Sept 2022
-
$61.71 M(-7.8%)
June 2022
-
$66.94 M(-10.7%)
Mar 2022
-
$74.99 M(-11.3%)
Dec 2021
$84.50 M(+3.6%)
$84.50 M(-2.4%)
Sept 2021
-
$86.61 M(-8.6%)
June 2021
-
$94.80 M(-5.2%)
Mar 2021
-
$100.03 M(+22.7%)
Dec 2020
$81.54 M(+11.7%)
$81.54 M(-10.9%)
Sept 2020
-
$91.53 M(+44.5%)
June 2020
-
$63.34 M(-10.0%)
Mar 2020
-
$70.36 M(-3.6%)
Dec 2019
$73.00 M(-33.3%)
$73.00 M(-9.2%)
Sept 2019
-
$80.37 M(-9.7%)
June 2019
-
$89.04 M(-14.5%)
Mar 2019
-
$104.20 M(-4.8%)
Dec 2018
$109.46 M(+184.0%)
$109.46 M(-3.4%)
Sept 2018
-
$113.32 M(+35.7%)
June 2018
-
$83.52 M(+23.5%)
Mar 2018
-
$67.62 M(+75.5%)
Dec 2017
$38.54 M(+85.4%)
$38.54 M(+147.4%)
Sept 2017
-
$15.58 M(-8.5%)
June 2017
-
$17.03 M(-11.5%)
Mar 2017
-
$19.24 M(-7.4%)
Dec 2016
$20.78 M(-441.4%)
$20.78 M(+29.7%)
Sept 2016
-
$16.02 M(+59.8%)
June 2016
-
$10.02 M(+116.2%)
Mar 2016
-
$4.64 M(-176.2%)
Dec 2015
-$6.09 M(+1341.8%)
-$6.09 M(+28.6%)
Sept 2015
-
-$4.73 M(+37.2%)
June 2015
-
-$3.45 M(+88.9%)
Mar 2015
-
-$1.83 M(+332.5%)
Dec 2014
-$422.20 K(-102.8%)
-$422.20 K(-150.4%)
Sept 2014
-
$837.70 K(-93.4%)
June 2014
-
$12.74 M(-8.1%)
Mar 2014
-
$13.86 M(-7.2%)
Dec 2013
$14.94 M(+81.4%)
$14.94 M(-5.2%)
Sept 2013
-
$15.76 M(-6.1%)
June 2013
-
$16.79 M(-5.1%)
Mar 2013
-
$17.69 M(+114.8%)
Dec 2012
$8.24 M(+225.3%)
$8.24 M(-1.5%)
Sept 2012
-
$8.36 M(-10.0%)
June 2012
-
$9.29 M(+284.0%)
Mar 2012
-
$2.42 M(-4.4%)
Dec 2011
$2.53 M(-52.5%)
$2.53 M(+70.7%)
Sept 2011
-
$1.48 M(-46.7%)
June 2011
-
$2.78 M(-17.9%)
Mar 2011
-
$3.39 M(-36.4%)
Dec 2010
$5.33 M
$5.33 M(+25.2%)
Sept 2010
-
$4.26 M(+163.6%)
DateAnnualQuarterly
June 2010
-
$1.62 M(+97.8%)
Mar 2010
-
$817.30 K(-142.4%)
Dec 2009
-$1.93 M(-132.5%)
-$1.93 M(+534.4%)
Sept 2009
-
-$303.60 K(-27.0%)
June 2009
-
-$415.80 K(-116.4%)
Mar 2009
-
$2.54 M(-57.2%)
Dec 2008
$5.92 M(-78.0%)
$5.92 M(-27.0%)
Sept 2008
-
$8.12 M(-28.8%)
June 2008
-
$11.41 M(-39.2%)
Mar 2008
-
$18.75 M(-30.3%)
Dec 2007
$26.90 M(-42.7%)
$26.90 M(-9.0%)
Sept 2007
-
$29.57 M(-8.3%)
June 2007
-
$32.24 M(-18.6%)
Mar 2007
-
$39.61 M(-15.7%)
Dec 2006
$46.96 M(+59.9%)
$46.96 M(+29.9%)
Sept 2006
-
$36.15 M(-8.1%)
June 2006
-
$39.34 M(-12.4%)
Mar 2006
-
$44.92 M(+52.9%)
Dec 2005
$29.37 M(-17.7%)
$29.37 M(-7.2%)
Sept 2005
-
$31.65 M(-11.7%)
June 2005
-
$35.85 M(-10.9%)
Mar 2005
-
$40.23 M(+12.7%)
Dec 2004
$35.70 M(+2.4%)
$35.70 M(+57.5%)
Sept 2004
-
$22.67 M(-12.2%)
June 2004
-
$25.82 M(-13.6%)
Mar 2004
-
$29.89 M(-14.3%)
Dec 2003
$34.86 M(+232.2%)
$34.86 M(+74.8%)
Sept 2003
-
$19.94 M(-18.6%)
June 2003
-
$24.51 M(+95.5%)
Mar 2003
-
$12.54 M(+19.5%)
Dec 2002
$10.49 M(-54.8%)
$10.49 M(-215.7%)
Sept 2002
-
-$9.07 M(-438.0%)
June 2002
-
$2.68 M(-80.8%)
Mar 2002
-
$13.98 M(-39.7%)
Dec 2001
$23.19 M(+21.8%)
$23.19 M(-10.5%)
Sept 2001
-
$25.93 M(+30.8%)
June 2001
-
$19.82 M(-42.8%)
Mar 2001
-
$34.66 M(+82.1%)
Dec 2000
$19.04 M(-13.4%)
$19.04 M(-47.2%)
Sept 2000
-
$36.09 M(-23.4%)
June 2000
-
$47.08 M(+69.1%)
Mar 2000
-
$27.84 M(+26.6%)
Dec 1999
$21.98 M(-33.8%)
$21.98 M(-45.4%)
Sept 1999
-
$40.30 M(+119.0%)
June 1999
-
$18.40 M(-29.8%)
Mar 1999
-
$26.20 M(-21.1%)
Dec 1998
$33.20 M(-21.0%)
$33.20 M(-8.8%)
Sept 1998
-
$36.40 M(-7.8%)
June 1998
-
$39.50 M(+0.8%)
Mar 1998
-
$39.20 M(-6.7%)
Dec 1997
$42.00 M(-11.9%)
$42.00 M(-4.5%)
Sept 1997
-
$44.00 M(-3.9%)
June 1997
-
$45.80 M(-1.3%)
Mar 1997
-
$46.40 M(-2.7%)
Dec 1996
$47.70 M
$47.70 M(-2.1%)
Sept 1996
-
$48.70 M(-3.0%)
June 1996
-
$50.20 M(+2290.5%)
Mar 1996
-
$2.10 M

FAQ

  • What is CASI Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual shareholders equity year-on-year change?
  • What is CASI Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly shareholders equity year-on-year change?

What is CASI Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of CASI is $24.16 M

What is the all time high annual shareholders equity for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual stockholders equity is $109.46 M

What is CASI Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, CASI annual stockholders equity has changed by -$20.41 M (-45.79%)

What is CASI Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of CASI is $13.85 M

What is the all time high quarterly shareholders equity for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly stockholders equity is $113.32 M

What is CASI Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, CASI quarterly stockholders equity has changed by -$10.32 M (-42.70%)